478 related articles for article (PubMed ID: 16914693)
21. Spotlight on Interferon-beta-1b in relapsing-remitting and secondary progressive multiple sclerosis.
McCormack PL; Scott LJ
BioDrugs; 2004; 18(5):343-7. PubMed ID: 15377176
[TBL] [Abstract][Full Text] [Related]
22. Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.
Edan G; Kappos L; Montalbán X; Polman CH; Freedman MS; Hartung HP; Miller D; Barkhof F; Herrmann J; Lanius V; Stemper B; Pohl C; Sandbrink R; Pleimes D;
J Neurol Neurosurg Psychiatry; 2014 Nov; 85(11):1183-9. PubMed ID: 24218527
[TBL] [Abstract][Full Text] [Related]
23. Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome.
Hyun JW; Kim W; Huh SY; Park MS; Ahn SW; Cho JY; Kim BJ; Lee SH; Kim SH; Kim HJ
Mult Scler; 2019 Oct; 25(11):1488-1495. PubMed ID: 30043667
[TBL] [Abstract][Full Text] [Related]
24. Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis.
Penner IK; Stemper B; Calabrese P; Freedman MS; Polman CH; Edan G; Hartung HP; Miller DH; Montalbán X; Barkhof F; Pleimes D; Lanius V; Pohl C; Kappos L; Sandbrink R
Mult Scler; 2012 Oct; 18(10):1466-71. PubMed ID: 22492127
[TBL] [Abstract][Full Text] [Related]
25. Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.
McCormack PL; Scott LJ
CNS Drugs; 2004; 18(8):521-46. PubMed ID: 15182221
[TBL] [Abstract][Full Text] [Related]
26. Lack of association between antimyelin antibodies and progression to multiple sclerosis.
Kuhle J; Pohl C; Mehling M; Edan G; Freedman MS; Hartung HP; Polman CH; Miller DH; Montalban X; Barkhof F; Bauer L; Dahms S; Lindberg R; Kappos L; Sandbrink R
N Engl J Med; 2007 Jan; 356(4):371-8. PubMed ID: 17251533
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria.
O'Connor P; Kinkel RP; Kremenchutzky M
Mult Scler; 2009 Jun; 15(6):728-34. PubMed ID: 19482863
[TBL] [Abstract][Full Text] [Related]
28. IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Kinkel RP; Kollman C; O'Connor P; Murray TJ; Simon J; Arnold D; Bakshi R; Weinstock-Gutman B; Brod S; Cooper J; Duquette P; Eggenberger E; Felton W; Fox R; Freedman M; Galetta S; Goodman A; Guarnaccia J; Hashimoto S; Horowitz S; Javerbaum J; Kasper L; Kaufman M; Kerson L; Mass M; Rammohan K; Reiss M; Rolak L; Rose J; Scott T; Selhorst J; Shin R; Smith C; Stuart W; Thurston S; Wall M;
Neurology; 2006 Mar; 66(5):678-84. PubMed ID: 16436649
[TBL] [Abstract][Full Text] [Related]
29. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.
Neurology; 1993 Apr; 43(4):655-61. PubMed ID: 8469318
[TBL] [Abstract][Full Text] [Related]
30. A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.
Montalban X; Sastre-Garriga J; Tintoré M; Brieva L; Aymerich FX; Río J; Porcel J; Borràs C; Nos C; Rovira A
Mult Scler; 2009 Oct; 15(10):1195-205. PubMed ID: 19797261
[TBL] [Abstract][Full Text] [Related]
31. The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: a post hoc analysis of data from CHAMPS.
O'Connor P;
Clin Ther; 2003 Nov; 25(11):2865-74. PubMed ID: 14693310
[TBL] [Abstract][Full Text] [Related]
32. Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event.
Pakdaman H; Sahraian MA; Fallah A; Pakdaman R; Ghareghozli K; Ghafarpour M; Rahimian E; Shirani A
Acta Neurol Scand; 2007 Jun; 115(6):429-31. PubMed ID: 17511854
[TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
Nikfar S; Rahimi R; Abdollahi M
Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482
[TBL] [Abstract][Full Text] [Related]
34. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Koch MW; Mostert JP; de Vries JJ; De Keyser J
Neurology; 2007 Apr; 68(14):1163; author reply 1163-4. PubMed ID: 17404207
[No Abstract] [Full Text] [Related]
35. Interferon beta treatment for multiple sclerosis: persisting questions.
Goodkin DE
Mult Scler; 1996 Jul; 1(6):321-4. PubMed ID: 9345408
[TBL] [Abstract][Full Text] [Related]
36. [Clinically isolated syndrome: prognostic markers for conversion to multiple sclerosis and initiation of disease-modifying therapy].
Kohriyama T
Rinsho Shinkeigaku; 2011 Mar; 51(3):179-87. PubMed ID: 21485162
[TBL] [Abstract][Full Text] [Related]
37. Beta interferons in clinically isolated syndromes: a meta-analysis.
Melo A; Rodrigues B; Bar-Or A
Arq Neuropsiquiatr; 2008 Mar; 66(1):8-10. PubMed ID: 18392405
[TBL] [Abstract][Full Text] [Related]
38. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study.
Saida T; Tashiro K; Itoyama Y; Sato T; Ohashi Y; Zhao Z;
Neurology; 2005 Feb; 64(4):621-30. PubMed ID: 15728282
[TBL] [Abstract][Full Text] [Related]
39. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.
Comi G; Filippi M; Barkhof F; Durelli L; Edan G; Fernández O; Hartung H; Seeldrayers P; Sørensen PS; Rovaris M; Martinelli V; Hommes OR;
Lancet; 2001 May; 357(9268):1576-82. PubMed ID: 11377645
[TBL] [Abstract][Full Text] [Related]
40. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial.
Filippi M; Rovaris M; Inglese M; Barkhof F; De Stefano N; Smith S; Comi G
Lancet; 2004 Oct 23-29; 364(9444):1489-96. PubMed ID: 15500893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
